Brigham Heart & Vascular at ACC 2024
Brigham and Women’s Hospital cardiovascular experts will present their latest research at this year’s American College of Cardiology 2024 Scientific Session & Expo, held April 6–8 in Atlanta, GA.
Read More...Latest Clinical & Research News
Specialty: Heart & Vascular
Brigham and Women’s Hospital cardiovascular experts will present their latest research at this year’s American College of Cardiology 2024 Scientific Session & Expo, held April 6–8 in Atlanta, GA.
Read More...The Brigham was part of a trial that shows for the first time that the weight loss drug semaglutide lowers the incidence of death from cardiovascular causes in those with overweight or obesity but not diabetes. Jorge Plutzky, MD, discusses the findings and implications for clinical care.
Read More...Paul M. Ridker, MD, MPH, of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital, and colleagues found inflammation assessed by hsCRP predicted cardiovascular events and death at least as strongly as LDLC when comparing bempedoic acid with placebo in statin-intolerant patients.
Read More...Shinichi Goto, PhD, at Brigham and Women’s Hospital, and colleagues have developed a deep learning–based model that detects subtle changes in standard 12-lead electrocardiography data to flag patients who should undergo echocardiography to evaluate possible atrial septal defect.
Read More...The fact that cardiovascular disease is the leading cause of death in women is wildly underappreciated, says the Brigham’s JoAnn E. Manson, MD, MPH, DrPH. Dr. Manson has led many seminal research projects focused on women’s health and set the foundation for related advances at the Brigham today.
Read More...Brigham and Women’s Hospital researchers report an initial decline in estimated glomerular filtration rate (eGFR) on initiation of dapagliflozin was not associated with adverse cardiovascular or kidney outcomes and did not appear to alter the long-term trajectory of eGFR decline.
Read More...Researchers at Brigham and Women’s Hospital determined the middle cerebral artery, circle of Willis, and paired superficial temporal artery (STA) are all feasible control vessels for transcriptomic studies of cerebrovascular diseases.
Read More...Brigham and Women’s Hospital researchers conducted a patient-level meta-analysis of ACUITY plus four other large randomized trials. Bivalirudin was not associated with any significant difference in 30-day effectiveness outcomes compared with heparin, but had a substantially better safety profile.
Read More...Researchers at Brigham and Women’s Hospital recently completed the first study that assessed the macroeconomic consequences of stroke and its subtypes globally in a standardized way.
Read More...Using contemporary data sets reflecting current clinical practices, researchers at Brigham and Women’s Hospital developed the TIMI Risk Score for Atherothrombosis in Diabetes, which uses information readily available from the medical chart to predict atherothrombotic complications in patients with type 2 diabetes.
Read More...